nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR2—coronary artery disease	0.232	0.619	CbGaD
Raloxifene—ESR1—coronary artery disease	0.143	0.381	CbGaD
Raloxifene—CYP2C8—Fenofibrate—coronary artery disease	0.0338	0.0949	CbGbCtD
Raloxifene—CYP2B6—Clopidogrel—coronary artery disease	0.0309	0.0869	CbGbCtD
Raloxifene—CYP2C8—Gemfibrozil—coronary artery disease	0.027	0.0759	CbGbCtD
Raloxifene—CYP2C8—Clopidogrel—coronary artery disease	0.0234	0.0658	CbGbCtD
Raloxifene—CYP2C8—Pitavastatin—coronary artery disease	0.0205	0.0575	CbGbCtD
Raloxifene—CYP2B6—Simvastatin—coronary artery disease	0.0185	0.052	CbGbCtD
Raloxifene—CYP2B6—Atorvastatin—coronary artery disease	0.0165	0.0464	CbGbCtD
Raloxifene—CYP3A4—Ticagrelor—coronary artery disease	0.0154	0.0432	CbGbCtD
Raloxifene—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0147	0.0413	CbGbCtD
Raloxifene—CYP2C8—Simvastatin—coronary artery disease	0.014	0.0394	CbGbCtD
Raloxifene—CYP2C8—Pravastatin—coronary artery disease	0.0137	0.0386	CbGbCtD
Raloxifene—CYP2C8—Lovastatin—coronary artery disease	0.0137	0.0386	CbGbCtD
Raloxifene—CYP3A4—Fenofibrate—coronary artery disease	0.0137	0.0385	CbGbCtD
Raloxifene—CYP2C8—Atorvastatin—coronary artery disease	0.0125	0.0351	CbGbCtD
Raloxifene—CYP2C8—Losartan—coronary artery disease	0.0114	0.0321	CbGbCtD
Raloxifene—CYP3A4—Gemfibrozil—coronary artery disease	0.011	0.0308	CbGbCtD
Raloxifene—CYP3A4—Clopidogrel—coronary artery disease	0.00949	0.0267	CbGbCtD
Raloxifene—CYP3A4—Eplerenone—coronary artery disease	0.00883	0.0248	CbGbCtD
Raloxifene—CYP3A4—Enalapril—coronary artery disease	0.00787	0.0221	CbGbCtD
Raloxifene—HTR2B—cardial valve—coronary artery disease	0.00678	0.477	CbGeAlD
Raloxifene—CYP3A4—Rosuvastatin—coronary artery disease	0.00612	0.0172	CbGbCtD
Raloxifene—CYP3A4—Ezetimibe—coronary artery disease	0.00612	0.0172	CbGbCtD
Raloxifene—CYP3A4—Simvastatin—coronary artery disease	0.00569	0.016	CbGbCtD
Raloxifene—CYP3A4—Pravastatin—coronary artery disease	0.00557	0.0156	CbGbCtD
Raloxifene—CYP3A4—Lovastatin—coronary artery disease	0.00557	0.0156	CbGbCtD
Raloxifene—CYP3A4—Atorvastatin—coronary artery disease	0.00507	0.0142	CbGbCtD
Raloxifene—CYP3A4—Losartan—coronary artery disease	0.00464	0.013	CbGbCtD
Raloxifene—Flavoxate—PDE4B—coronary artery disease	0.000801	1	CrCbGaD
Raloxifene—SIGMAR1—cardiac ventricle—coronary artery disease	0.000572	0.0402	CbGeAlD
Raloxifene—SIGMAR1—myocardium—coronary artery disease	0.000538	0.0378	CbGeAlD
Raloxifene—ESR2—heart—coronary artery disease	0.000485	0.0341	CbGeAlD
Raloxifene—AOX1—heart—coronary artery disease	0.000466	0.0328	CbGeAlD
Raloxifene—ESR2—cardiovascular system—coronary artery disease	0.000457	0.0322	CbGeAlD
Raloxifene—AOX1—cardiac atrium—coronary artery disease	0.000399	0.0281	CbGeAlD
Raloxifene—SIGMAR1—heart—coronary artery disease	0.000375	0.0264	CbGeAlD
Raloxifene—HTR2B—heart—coronary artery disease	0.000375	0.0263	CbGeAlD
Raloxifene—ESR2—blood—coronary artery disease	0.000362	0.0254	CbGeAlD
Raloxifene—HTR2B—cardiovascular system—coronary artery disease	0.000354	0.0249	CbGeAlD
Raloxifene—ESR1—heart—coronary artery disease	0.000332	0.0233	CbGeAlD
Raloxifene—SIGMAR1—cardiac atrium—coronary artery disease	0.000321	0.0226	CbGeAlD
Raloxifene—ESR1—cardiovascular system—coronary artery disease	0.000313	0.022	CbGeAlD
Raloxifene—CYP19A1—blood—coronary artery disease	0.000285	0.02	CbGeAlD
Raloxifene—SIGMAR1—blood—coronary artery disease	0.00028	0.0197	CbGeAlD
Raloxifene—HTR2B—blood—coronary artery disease	0.00028	0.0197	CbGeAlD
Raloxifene—ESR1—blood—coronary artery disease	0.000248	0.0174	CbGeAlD
Raloxifene—CYP2B6—heart—coronary artery disease	0.000245	0.0172	CbGeAlD
Raloxifene—CYP2B6—cardiovascular system—coronary artery disease	0.000231	0.0163	CbGeAlD
Raloxifene—CYP2C8—blood—coronary artery disease	0.000204	0.0143	CbGeAlD
Raloxifene—CYP2B6—blood—coronary artery disease	0.000183	0.0129	CbGeAlD
Raloxifene—CYP3A4—blood—coronary artery disease	0.000138	0.00972	CbGeAlD
Raloxifene—Nervous system disorder—Losartan—coronary artery disease	9.4e-05	0.000583	CcSEcCtD
Raloxifene—Thrombocytopenia—Losartan—coronary artery disease	9.39e-05	0.000582	CcSEcCtD
Raloxifene—Abdominal pain—Valsartan—coronary artery disease	9.37e-05	0.000581	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Telmisartan—coronary artery disease	9.35e-05	0.00058	CcSEcCtD
Raloxifene—Abdominal pain—Olmesartan—coronary artery disease	9.33e-05	0.000579	CcSEcCtD
Raloxifene—Body temperature increased—Olmesartan—coronary artery disease	9.33e-05	0.000579	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Perindopril—coronary artery disease	9.31e-05	0.000578	CcSEcCtD
Raloxifene—Gastrointestinal pain—Pravastatin—coronary artery disease	9.28e-05	0.000576	CcSEcCtD
Raloxifene—Hyperhidrosis—Losartan—coronary artery disease	9.27e-05	0.000575	CcSEcCtD
Raloxifene—Dyspepsia—Captopril—coronary artery disease	9.27e-05	0.000575	CcSEcCtD
Raloxifene—Pain—Telmisartan—coronary artery disease	9.26e-05	0.000574	CcSEcCtD
Raloxifene—Insomnia—Perindopril—coronary artery disease	9.25e-05	0.000574	CcSEcCtD
Raloxifene—Diarrhoea—Clopidogrel—coronary artery disease	9.24e-05	0.000573	CcSEcCtD
Raloxifene—Diarrhoea—Lovastatin—coronary artery disease	9.18e-05	0.00057	CcSEcCtD
Raloxifene—Nausea—Acetylsalicylic acid—coronary artery disease	9.14e-05	0.000567	CcSEcCtD
Raloxifene—Abdominal pain—Niacin—coronary artery disease	9.11e-05	0.000565	CcSEcCtD
Raloxifene—Body temperature increased—Niacin—coronary artery disease	9.11e-05	0.000565	CcSEcCtD
Raloxifene—Dizziness—Fenofibrate—coronary artery disease	9.09e-05	0.000564	CcSEcCtD
Raloxifene—Vertigo—Ramipril—coronary artery disease	9.05e-05	0.000561	CcSEcCtD
Raloxifene—Syncope—Ramipril—coronary artery disease	9.03e-05	0.00056	CcSEcCtD
Raloxifene—Gastrointestinal pain—Trandolapril—coronary artery disease	9.01e-05	0.000559	CcSEcCtD
Raloxifene—Diarrhoea—Ezetimibe—coronary artery disease	9.01e-05	0.000559	CcSEcCtD
Raloxifene—Flatulence—Lisinopril—coronary artery disease	9e-05	0.000558	CcSEcCtD
Raloxifene—Dyspepsia—Perindopril—coronary artery disease	9e-05	0.000558	CcSEcCtD
Raloxifene—Gastrointestinal pain—Enalapril—coronary artery disease	8.98e-05	0.000557	CcSEcCtD
Raloxifene—Abdominal pain—Pravastatin—coronary artery disease	8.97e-05	0.000557	CcSEcCtD
Raloxifene—Body temperature increased—Pravastatin—coronary artery disease	8.97e-05	0.000557	CcSEcCtD
Raloxifene—Dizziness—Clopidogrel—coronary artery disease	8.93e-05	0.000554	CcSEcCtD
Raloxifene—Dizziness—Lovastatin—coronary artery disease	8.87e-05	0.000551	CcSEcCtD
Raloxifene—Loss of consciousness—Ramipril—coronary artery disease	8.85e-05	0.000549	CcSEcCtD
Raloxifene—Gastrointestinal pain—Telmisartan—coronary artery disease	8.85e-05	0.000549	CcSEcCtD
Raloxifene—Vertigo—Timolol—coronary artery disease	8.85e-05	0.000549	CcSEcCtD
Raloxifene—Syncope—Timolol—coronary artery disease	8.83e-05	0.000548	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Perindopril—coronary artery disease	8.82e-05	0.000547	CcSEcCtD
Raloxifene—Diarrhoea—Eplerenone—coronary artery disease	8.82e-05	0.000547	CcSEcCtD
Raloxifene—Cough—Ramipril—coronary artery disease	8.79e-05	0.000545	CcSEcCtD
Raloxifene—Muscle spasms—Lisinopril—coronary artery disease	8.78e-05	0.000545	CcSEcCtD
Raloxifene—Pain—Perindopril—coronary artery disease	8.74e-05	0.000542	CcSEcCtD
Raloxifene—Vomiting—Fenofibrate—coronary artery disease	8.74e-05	0.000542	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Losartan—coronary artery disease	8.74e-05	0.000542	CcSEcCtD
Raloxifene—Abdominal pain—Trandolapril—coronary artery disease	8.71e-05	0.00054	CcSEcCtD
Raloxifene—Body temperature increased—Trandolapril—coronary artery disease	8.71e-05	0.00054	CcSEcCtD
Raloxifene—Dizziness—Ezetimibe—coronary artery disease	8.7e-05	0.00054	CcSEcCtD
Raloxifene—Abdominal pain—Enalapril—coronary artery disease	8.68e-05	0.000538	CcSEcCtD
Raloxifene—Body temperature increased—Enalapril—coronary artery disease	8.68e-05	0.000538	CcSEcCtD
Raloxifene—Insomnia—Losartan—coronary artery disease	8.67e-05	0.000538	CcSEcCtD
Raloxifene—Rash—Fenofibrate—coronary artery disease	8.67e-05	0.000538	CcSEcCtD
Raloxifene—Dermatitis—Fenofibrate—coronary artery disease	8.66e-05	0.000537	CcSEcCtD
Raloxifene—Loss of consciousness—Timolol—coronary artery disease	8.66e-05	0.000537	CcSEcCtD
Raloxifene—Headache—Fenofibrate—coronary artery disease	8.61e-05	0.000534	CcSEcCtD
Raloxifene—Gastrointestinal pain—Captopril—coronary artery disease	8.61e-05	0.000534	CcSEcCtD
Raloxifene—Cough—Timolol—coronary artery disease	8.59e-05	0.000533	CcSEcCtD
Raloxifene—Vomiting—Clopidogrel—coronary artery disease	8.59e-05	0.000533	CcSEcCtD
Raloxifene—Diarrhoea—Simvastatin—coronary artery disease	8.59e-05	0.000533	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Furosemide—coronary artery disease	8.58e-05	0.000532	CcSEcCtD
Raloxifene—Myalgia—Ramipril—coronary artery disease	8.58e-05	0.000532	CcSEcCtD
Raloxifene—Arthralgia—Ramipril—coronary artery disease	8.58e-05	0.000532	CcSEcCtD
Raloxifene—Chest pain—Ramipril—coronary artery disease	8.58e-05	0.000532	CcSEcCtD
Raloxifene—Abdominal pain—Telmisartan—coronary artery disease	8.56e-05	0.000531	CcSEcCtD
Raloxifene—Body temperature increased—Telmisartan—coronary artery disease	8.56e-05	0.000531	CcSEcCtD
Raloxifene—Vomiting—Lovastatin—coronary artery disease	8.53e-05	0.000529	CcSEcCtD
Raloxifene—Dizziness—Eplerenone—coronary artery disease	8.52e-05	0.000529	CcSEcCtD
Raloxifene—Rash—Clopidogrel—coronary artery disease	8.52e-05	0.000528	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	8.52e-05	0.000528	CcSEcCtD
Raloxifene—Dermatitis—Clopidogrel—coronary artery disease	8.51e-05	0.000528	CcSEcCtD
Raloxifene—Pain—Furosemide—coronary artery disease	8.5e-05	0.000527	CcSEcCtD
Raloxifene—Headache—Clopidogrel—coronary artery disease	8.46e-05	0.000525	CcSEcCtD
Raloxifene—Rash—Lovastatin—coronary artery disease	8.46e-05	0.000525	CcSEcCtD
Raloxifene—Dermatitis—Lovastatin—coronary artery disease	8.45e-05	0.000524	CcSEcCtD
Raloxifene—Dyspepsia—Losartan—coronary artery disease	8.44e-05	0.000524	CcSEcCtD
Raloxifene—Headache—Lovastatin—coronary artery disease	8.41e-05	0.000522	CcSEcCtD
Raloxifene—Arthralgia—Timolol—coronary artery disease	8.38e-05	0.00052	CcSEcCtD
Raloxifene—Chest pain—Timolol—coronary artery disease	8.38e-05	0.00052	CcSEcCtD
Raloxifene—Myalgia—Timolol—coronary artery disease	8.38e-05	0.00052	CcSEcCtD
Raloxifene—Vomiting—Ezetimibe—coronary artery disease	8.37e-05	0.000519	CcSEcCtD
Raloxifene—Gastrointestinal pain—Perindopril—coronary artery disease	8.36e-05	0.000519	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	8.33e-05	0.000516	CcSEcCtD
Raloxifene—Abdominal pain—Captopril—coronary artery disease	8.32e-05	0.000516	CcSEcCtD
Raloxifene—Body temperature increased—Captopril—coronary artery disease	8.32e-05	0.000516	CcSEcCtD
Raloxifene—Dizziness—Simvastatin—coronary artery disease	8.3e-05	0.000515	CcSEcCtD
Raloxifene—Rash—Ezetimibe—coronary artery disease	8.3e-05	0.000515	CcSEcCtD
Raloxifene—Dermatitis—Ezetimibe—coronary artery disease	8.29e-05	0.000514	CcSEcCtD
Raloxifene—Headache—Ezetimibe—coronary artery disease	8.25e-05	0.000512	CcSEcCtD
Raloxifene—Vertigo—Lisinopril—coronary artery disease	8.21e-05	0.000509	CcSEcCtD
Raloxifene—Pain—Losartan—coronary artery disease	8.2e-05	0.000509	CcSEcCtD
Raloxifene—Syncope—Lisinopril—coronary artery disease	8.19e-05	0.000508	CcSEcCtD
Raloxifene—Vomiting—Eplerenone—coronary artery disease	8.19e-05	0.000508	CcSEcCtD
Raloxifene—Nausea—Fenofibrate—coronary artery disease	8.16e-05	0.000506	CcSEcCtD
Raloxifene—Gastrointestinal pain—Furosemide—coronary artery disease	8.13e-05	0.000504	CcSEcCtD
Raloxifene—Rash—Eplerenone—coronary artery disease	8.12e-05	0.000504	CcSEcCtD
Raloxifene—Dermatitis—Eplerenone—coronary artery disease	8.12e-05	0.000503	CcSEcCtD
Raloxifene—Diarrhoea—Valsartan—coronary artery disease	8.11e-05	0.000503	CcSEcCtD
Raloxifene—Shock—Ramipril—coronary artery disease	8.09e-05	0.000502	CcSEcCtD
Raloxifene—Abdominal pain—Perindopril—coronary artery disease	8.08e-05	0.000501	CcSEcCtD
Raloxifene—Body temperature increased—Perindopril—coronary artery disease	8.08e-05	0.000501	CcSEcCtD
Raloxifene—Diarrhoea—Olmesartan—coronary artery disease	8.07e-05	0.000501	CcSEcCtD
Raloxifene—Headache—Eplerenone—coronary artery disease	8.07e-05	0.000501	CcSEcCtD
Raloxifene—Nervous system disorder—Ramipril—coronary artery disease	8.06e-05	0.0005	CcSEcCtD
Raloxifene—Thrombocytopenia—Ramipril—coronary artery disease	8.05e-05	0.000499	CcSEcCtD
Raloxifene—Loss of consciousness—Lisinopril—coronary artery disease	8.03e-05	0.000498	CcSEcCtD
Raloxifene—Nausea—Clopidogrel—coronary artery disease	8.02e-05	0.000498	CcSEcCtD
Raloxifene—Skin disorder—Ramipril—coronary artery disease	7.99e-05	0.000495	CcSEcCtD
Raloxifene—Infection—Timolol—coronary artery disease	7.98e-05	0.000495	CcSEcCtD
Raloxifene—Vomiting—Simvastatin—coronary artery disease	7.98e-05	0.000495	CcSEcCtD
Raloxifene—Cough—Lisinopril—coronary artery disease	7.97e-05	0.000495	CcSEcCtD
Raloxifene—Nausea—Lovastatin—coronary artery disease	7.97e-05	0.000495	CcSEcCtD
Raloxifene—Hyperhidrosis—Ramipril—coronary artery disease	7.95e-05	0.000493	CcSEcCtD
Raloxifene—Rash—Simvastatin—coronary artery disease	7.91e-05	0.000491	CcSEcCtD
Raloxifene—Dermatitis—Simvastatin—coronary artery disease	7.91e-05	0.000491	CcSEcCtD
Raloxifene—Shock—Timolol—coronary artery disease	7.91e-05	0.000491	CcSEcCtD
Raloxifene—Diarrhoea—Niacin—coronary artery disease	7.89e-05	0.000489	CcSEcCtD
Raloxifene—Nervous system disorder—Timolol—coronary artery disease	7.88e-05	0.000489	CcSEcCtD
Raloxifene—Headache—Simvastatin—coronary artery disease	7.86e-05	0.000488	CcSEcCtD
Raloxifene—Abdominal pain—Furosemide—coronary artery disease	7.86e-05	0.000487	CcSEcCtD
Raloxifene—Body temperature increased—Furosemide—coronary artery disease	7.86e-05	0.000487	CcSEcCtD
Raloxifene—Gastrointestinal pain—Losartan—coronary artery disease	7.84e-05	0.000486	CcSEcCtD
Raloxifene—Dizziness—Valsartan—coronary artery disease	7.84e-05	0.000486	CcSEcCtD
Raloxifene—Nausea—Ezetimibe—coronary artery disease	7.82e-05	0.000485	CcSEcCtD
Raloxifene—Skin disorder—Timolol—coronary artery disease	7.81e-05	0.000484	CcSEcCtD
Raloxifene—Dizziness—Olmesartan—coronary artery disease	7.8e-05	0.000484	CcSEcCtD
Raloxifene—Chest pain—Lisinopril—coronary artery disease	7.78e-05	0.000482	CcSEcCtD
Raloxifene—Arthralgia—Lisinopril—coronary artery disease	7.78e-05	0.000482	CcSEcCtD
Raloxifene—Myalgia—Lisinopril—coronary artery disease	7.78e-05	0.000482	CcSEcCtD
Raloxifene—Hyperhidrosis—Timolol—coronary artery disease	7.77e-05	0.000482	CcSEcCtD
Raloxifene—Diarrhoea—Pravastatin—coronary artery disease	7.77e-05	0.000482	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.72e-05	0.000479	CcSEcCtD
Raloxifene—Nausea—Eplerenone—coronary artery disease	7.65e-05	0.000475	CcSEcCtD
Raloxifene—Dizziness—Niacin—coronary artery disease	7.62e-05	0.000473	CcSEcCtD
Raloxifene—Body temperature increased—Losartan—coronary artery disease	7.58e-05	0.00047	CcSEcCtD
Raloxifene—Abdominal pain—Losartan—coronary artery disease	7.58e-05	0.00047	CcSEcCtD
Raloxifene—Diarrhoea—Trandolapril—coronary artery disease	7.54e-05	0.000468	CcSEcCtD
Raloxifene—Vomiting—Valsartan—coronary artery disease	7.54e-05	0.000468	CcSEcCtD
Raloxifene—Diarrhoea—Enalapril—coronary artery disease	7.51e-05	0.000466	CcSEcCtD
Raloxifene—Dizziness—Pravastatin—coronary artery disease	7.5e-05	0.000466	CcSEcCtD
Raloxifene—Vomiting—Olmesartan—coronary artery disease	7.5e-05	0.000465	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Ramipril—coronary artery disease	7.49e-05	0.000465	CcSEcCtD
Raloxifene—Rash—Valsartan—coronary artery disease	7.47e-05	0.000464	CcSEcCtD
Raloxifene—Dermatitis—Valsartan—coronary artery disease	7.47e-05	0.000463	CcSEcCtD
Raloxifene—Nausea—Simvastatin—coronary artery disease	7.46e-05	0.000463	CcSEcCtD
Raloxifene—Rash—Olmesartan—coronary artery disease	7.44e-05	0.000461	CcSEcCtD
Raloxifene—Insomnia—Ramipril—coronary artery disease	7.44e-05	0.000461	CcSEcCtD
Raloxifene—Dermatitis—Olmesartan—coronary artery disease	7.43e-05	0.000461	CcSEcCtD
Raloxifene—Headache—Valsartan—coronary artery disease	7.43e-05	0.000461	CcSEcCtD
Raloxifene—Diarrhoea—Telmisartan—coronary artery disease	7.41e-05	0.00046	CcSEcCtD
Raloxifene—Infection—Lisinopril—coronary artery disease	7.41e-05	0.000459	CcSEcCtD
Raloxifene—Headache—Olmesartan—coronary artery disease	7.39e-05	0.000458	CcSEcCtD
Raloxifene—Shock—Lisinopril—coronary artery disease	7.34e-05	0.000455	CcSEcCtD
Raloxifene—Vomiting—Niacin—coronary artery disease	7.33e-05	0.000455	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Timolol—coronary artery disease	7.32e-05	0.000454	CcSEcCtD
Raloxifene—Thrombocytopenia—Lisinopril—coronary artery disease	7.3e-05	0.000453	CcSEcCtD
Raloxifene—Dizziness—Trandolapril—coronary artery disease	7.29e-05	0.000452	CcSEcCtD
Raloxifene—Insomnia—Timolol—coronary artery disease	7.27e-05	0.000451	CcSEcCtD
Raloxifene—Rash—Niacin—coronary artery disease	7.27e-05	0.000451	CcSEcCtD
Raloxifene—Dermatitis—Niacin—coronary artery disease	7.26e-05	0.00045	CcSEcCtD
Raloxifene—Dizziness—Enalapril—coronary artery disease	7.26e-05	0.00045	CcSEcCtD
Raloxifene—Skin disorder—Lisinopril—coronary artery disease	7.24e-05	0.000449	CcSEcCtD
Raloxifene—Dyspepsia—Ramipril—coronary artery disease	7.24e-05	0.000449	CcSEcCtD
Raloxifene—Headache—Niacin—coronary artery disease	7.22e-05	0.000448	CcSEcCtD
Raloxifene—Vomiting—Pravastatin—coronary artery disease	7.22e-05	0.000448	CcSEcCtD
Raloxifene—Hyperhidrosis—Lisinopril—coronary artery disease	7.21e-05	0.000447	CcSEcCtD
Raloxifene—Diarrhoea—Captopril—coronary artery disease	7.2e-05	0.000447	CcSEcCtD
Raloxifene—Dizziness—Telmisartan—coronary artery disease	7.16e-05	0.000444	CcSEcCtD
Raloxifene—Rash—Pravastatin—coronary artery disease	7.16e-05	0.000444	CcSEcCtD
Raloxifene—Dermatitis—Pravastatin—coronary artery disease	7.15e-05	0.000443	CcSEcCtD
Raloxifene—Headache—Pravastatin—coronary artery disease	7.11e-05	0.000441	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Ramipril—coronary artery disease	7.1e-05	0.00044	CcSEcCtD
Raloxifene—Dyspepsia—Timolol—coronary artery disease	7.07e-05	0.000439	CcSEcCtD
Raloxifene—Nausea—Valsartan—coronary artery disease	7.04e-05	0.000437	CcSEcCtD
Raloxifene—Nausea—Olmesartan—coronary artery disease	7.01e-05	0.000435	CcSEcCtD
Raloxifene—Vomiting—Trandolapril—coronary artery disease	7.01e-05	0.000435	CcSEcCtD
Raloxifene—Diarrhoea—Perindopril—coronary artery disease	6.99e-05	0.000434	CcSEcCtD
Raloxifene—Vomiting—Enalapril—coronary artery disease	6.98e-05	0.000433	CcSEcCtD
Raloxifene—Dizziness—Captopril—coronary artery disease	6.96e-05	0.000432	CcSEcCtD
Raloxifene—Rash—Trandolapril—coronary artery disease	6.95e-05	0.000431	CcSEcCtD
Raloxifene—Dermatitis—Trandolapril—coronary artery disease	6.94e-05	0.000431	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Timolol—coronary artery disease	6.94e-05	0.00043	CcSEcCtD
Raloxifene—Rash—Enalapril—coronary artery disease	6.92e-05	0.000429	CcSEcCtD
Raloxifene—Dermatitis—Enalapril—coronary artery disease	6.91e-05	0.000429	CcSEcCtD
Raloxifene—Headache—Trandolapril—coronary artery disease	6.9e-05	0.000428	CcSEcCtD
Raloxifene—Vomiting—Telmisartan—coronary artery disease	6.88e-05	0.000427	CcSEcCtD
Raloxifene—Headache—Enalapril—coronary artery disease	6.88e-05	0.000427	CcSEcCtD
Raloxifene—Pain—Timolol—coronary artery disease	6.87e-05	0.000426	CcSEcCtD
Raloxifene—Nausea—Niacin—coronary artery disease	6.85e-05	0.000425	CcSEcCtD
Raloxifene—Rash—Telmisartan—coronary artery disease	6.83e-05	0.000423	CcSEcCtD
Raloxifene—Dermatitis—Telmisartan—coronary artery disease	6.82e-05	0.000423	CcSEcCtD
Raloxifene—Diarrhoea—Furosemide—coronary artery disease	6.8e-05	0.000422	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.79e-05	0.000421	CcSEcCtD
Raloxifene—Headache—Telmisartan—coronary artery disease	6.78e-05	0.000421	CcSEcCtD
Raloxifene—Dizziness—Perindopril—coronary artery disease	6.76e-05	0.000419	CcSEcCtD
Raloxifene—Insomnia—Lisinopril—coronary artery disease	6.74e-05	0.000418	CcSEcCtD
Raloxifene—Nausea—Pravastatin—coronary artery disease	6.74e-05	0.000418	CcSEcCtD
Raloxifene—Gastrointestinal pain—Ramipril—coronary artery disease	6.72e-05	0.000417	CcSEcCtD
Raloxifene—Vomiting—Captopril—coronary artery disease	6.69e-05	0.000415	CcSEcCtD
Raloxifene—Rash—Captopril—coronary artery disease	6.64e-05	0.000412	CcSEcCtD
Raloxifene—Dermatitis—Captopril—coronary artery disease	6.63e-05	0.000411	CcSEcCtD
Raloxifene—Headache—Captopril—coronary artery disease	6.6e-05	0.000409	CcSEcCtD
Raloxifene—Gastrointestinal pain—Timolol—coronary artery disease	6.57e-05	0.000408	CcSEcCtD
Raloxifene—Dizziness—Furosemide—coronary artery disease	6.57e-05	0.000408	CcSEcCtD
Raloxifene—Dyspepsia—Lisinopril—coronary artery disease	6.56e-05	0.000407	CcSEcCtD
Raloxifene—Diarrhoea—Losartan—coronary artery disease	6.56e-05	0.000407	CcSEcCtD
Raloxifene—Nausea—Trandolapril—coronary artery disease	6.55e-05	0.000406	CcSEcCtD
Raloxifene—Nausea—Enalapril—coronary artery disease	6.52e-05	0.000404	CcSEcCtD
Raloxifene—Vomiting—Perindopril—coronary artery disease	6.5e-05	0.000403	CcSEcCtD
Raloxifene—Abdominal pain—Ramipril—coronary artery disease	6.5e-05	0.000403	CcSEcCtD
Raloxifene—Body temperature increased—Ramipril—coronary artery disease	6.5e-05	0.000403	CcSEcCtD
Raloxifene—Rash—Perindopril—coronary artery disease	6.44e-05	0.0004	CcSEcCtD
Raloxifene—Dermatitis—Perindopril—coronary artery disease	6.44e-05	0.000399	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.44e-05	0.000399	CcSEcCtD
Raloxifene—Nausea—Telmisartan—coronary artery disease	6.43e-05	0.000399	CcSEcCtD
Raloxifene—Headache—Perindopril—coronary artery disease	6.4e-05	0.000397	CcSEcCtD
Raloxifene—Pain—Lisinopril—coronary artery disease	6.38e-05	0.000396	CcSEcCtD
Raloxifene—Body temperature increased—Timolol—coronary artery disease	6.35e-05	0.000394	CcSEcCtD
Raloxifene—Abdominal pain—Timolol—coronary artery disease	6.35e-05	0.000394	CcSEcCtD
Raloxifene—Dizziness—Losartan—coronary artery disease	6.34e-05	0.000393	CcSEcCtD
Raloxifene—Vomiting—Furosemide—coronary artery disease	6.32e-05	0.000392	CcSEcCtD
Raloxifene—Rash—Furosemide—coronary artery disease	6.27e-05	0.000389	CcSEcCtD
Raloxifene—Dermatitis—Furosemide—coronary artery disease	6.26e-05	0.000388	CcSEcCtD
Raloxifene—Nausea—Captopril—coronary artery disease	6.25e-05	0.000388	CcSEcCtD
Raloxifene—Headache—Furosemide—coronary artery disease	6.23e-05	0.000386	CcSEcCtD
Raloxifene—Gastrointestinal pain—Lisinopril—coronary artery disease	6.1e-05	0.000378	CcSEcCtD
Raloxifene—Vomiting—Losartan—coronary artery disease	6.1e-05	0.000378	CcSEcCtD
Raloxifene—Nausea—Perindopril—coronary artery disease	6.07e-05	0.000377	CcSEcCtD
Raloxifene—Rash—Losartan—coronary artery disease	6.05e-05	0.000375	CcSEcCtD
Raloxifene—Dermatitis—Losartan—coronary artery disease	6.04e-05	0.000375	CcSEcCtD
Raloxifene—Headache—Losartan—coronary artery disease	6.01e-05	0.000373	CcSEcCtD
Raloxifene—Nausea—Furosemide—coronary artery disease	5.9e-05	0.000366	CcSEcCtD
Raloxifene—Abdominal pain—Lisinopril—coronary artery disease	5.89e-05	0.000366	CcSEcCtD
Raloxifene—Body temperature increased—Lisinopril—coronary artery disease	5.89e-05	0.000366	CcSEcCtD
Raloxifene—Nausea—Losartan—coronary artery disease	5.69e-05	0.000353	CcSEcCtD
Raloxifene—Diarrhoea—Ramipril—coronary artery disease	5.62e-05	0.000349	CcSEcCtD
Raloxifene—Diarrhoea—Timolol—coronary artery disease	5.5e-05	0.000341	CcSEcCtD
Raloxifene—Dizziness—Ramipril—coronary artery disease	5.44e-05	0.000337	CcSEcCtD
Raloxifene—Dizziness—Timolol—coronary artery disease	5.31e-05	0.00033	CcSEcCtD
Raloxifene—Vomiting—Ramipril—coronary artery disease	5.23e-05	0.000324	CcSEcCtD
Raloxifene—Rash—Ramipril—coronary artery disease	5.18e-05	0.000322	CcSEcCtD
Raloxifene—Dermatitis—Ramipril—coronary artery disease	5.18e-05	0.000321	CcSEcCtD
Raloxifene—Headache—Ramipril—coronary artery disease	5.15e-05	0.000319	CcSEcCtD
Raloxifene—Vomiting—Timolol—coronary artery disease	5.11e-05	0.000317	CcSEcCtD
Raloxifene—Diarrhoea—Lisinopril—coronary artery disease	5.1e-05	0.000316	CcSEcCtD
Raloxifene—Rash—Timolol—coronary artery disease	5.07e-05	0.000314	CcSEcCtD
Raloxifene—Dermatitis—Timolol—coronary artery disease	5.06e-05	0.000314	CcSEcCtD
Raloxifene—Headache—Timolol—coronary artery disease	5.03e-05	0.000312	CcSEcCtD
Raloxifene—Dizziness—Lisinopril—coronary artery disease	4.93e-05	0.000306	CcSEcCtD
Raloxifene—Nausea—Ramipril—coronary artery disease	4.88e-05	0.000303	CcSEcCtD
Raloxifene—Nausea—Timolol—coronary artery disease	4.77e-05	0.000296	CcSEcCtD
Raloxifene—Vomiting—Lisinopril—coronary artery disease	4.74e-05	0.000294	CcSEcCtD
Raloxifene—Rash—Lisinopril—coronary artery disease	4.7e-05	0.000292	CcSEcCtD
Raloxifene—Dermatitis—Lisinopril—coronary artery disease	4.7e-05	0.000291	CcSEcCtD
Raloxifene—Headache—Lisinopril—coronary artery disease	4.67e-05	0.00029	CcSEcCtD
Raloxifene—Nausea—Lisinopril—coronary artery disease	4.43e-05	0.000275	CcSEcCtD
Raloxifene—CYP2C8—Metabolism—CTGF—coronary artery disease	4.2e-06	4.53e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOB—coronary artery disease	4.2e-06	4.53e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—F2—coronary artery disease	4.16e-06	4.5e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FN1—coronary artery disease	4.16e-06	4.5e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMGCR—coronary artery disease	4.16e-06	4.49e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GOT2—coronary artery disease	4.16e-06	4.49e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6ST—coronary artery disease	4.15e-06	4.48e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HIF1A—coronary artery disease	4.13e-06	4.46e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDN1—coronary artery disease	4.13e-06	4.46e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NFKBIA—coronary artery disease	4.11e-06	4.44e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AGT—coronary artery disease	4.11e-06	4.44e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL5—coronary artery disease	4.1e-06	4.42e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.07e-06	4.4e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SERPINE1—coronary artery disease	4.05e-06	4.38e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CSF2—coronary artery disease	4.04e-06	4.36e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF1—coronary artery disease	4.04e-06	4.36e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—coronary artery disease	4.03e-06	4.35e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—coronary artery disease	4.03e-06	4.35e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LPL—coronary artery disease	4.01e-06	4.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LCAT—coronary artery disease	4e-06	4.32e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CPT1B—coronary artery disease	4e-06	4.32e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KIT—coronary artery disease	3.99e-06	4.3e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOA1—coronary artery disease	3.98e-06	4.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RPS6KB1—coronary artery disease	3.97e-06	4.29e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MEF2C—coronary artery disease	3.97e-06	4.29e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KDR—coronary artery disease	3.95e-06	4.26e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK14—coronary artery disease	3.92e-06	4.24e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA4—coronary artery disease	3.92e-06	4.24e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—coronary artery disease	3.91e-06	4.22e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ITGB3—coronary artery disease	3.87e-06	4.18e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—coronary artery disease	3.87e-06	4.18e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—coronary artery disease	3.85e-06	4.16e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ESR1—coronary artery disease	3.85e-06	4.16e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PLCB1—coronary artery disease	3.82e-06	4.13e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GSK3B—coronary artery disease	3.82e-06	4.13e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTP1—coronary artery disease	3.81e-06	4.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—F2—coronary artery disease	3.8e-06	4.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FN1—coronary artery disease	3.8e-06	4.11e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—coronary artery disease	3.79e-06	4.1e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CREB1—coronary artery disease	3.79e-06	4.1e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.79e-06	4.09e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCLM—coronary artery disease	3.79e-06	4.09e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6ST—coronary artery disease	3.79e-06	4.09e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	3.77e-06	4.08e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PPP2CA—coronary artery disease	3.76e-06	4.06e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—coronary artery disease	3.76e-06	4.06e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NFKBIA—coronary artery disease	3.76e-06	4.06e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.75e-06	4.05e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL2—coronary artery disease	3.71e-06	4.01e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCA1—coronary artery disease	3.71e-06	4e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAT—coronary artery disease	3.71e-06	4e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6R—coronary artery disease	3.7e-06	4e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCD—coronary artery disease	3.69e-06	3.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.67e-06	3.96e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.67e-06	3.96e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—coronary artery disease	3.66e-06	3.95e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—coronary artery disease	3.65e-06	3.94e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KIT—coronary artery disease	3.64e-06	3.93e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK1—coronary artery disease	3.63e-06	3.92e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.61e-06	3.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—coronary artery disease	3.61e-06	3.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—C3—coronary artery disease	3.61e-06	3.9e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOB—coronary artery disease	3.6e-06	3.89e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GOT1—coronary artery disease	3.59e-06	3.88e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GGT1—coronary artery disease	3.59e-06	3.88e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—coronary artery disease	3.57e-06	3.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.56e-06	3.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HADH—coronary artery disease	3.56e-06	3.85e-05	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—coronary artery disease	3.53e-06	3.81e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—coronary artery disease	3.51e-06	3.79e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—coronary artery disease	3.5e-06	3.78e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GSK3B—coronary artery disease	3.49e-06	3.77e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—coronary artery disease	3.47e-06	3.75e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—coronary artery disease	3.46e-06	3.74e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—coronary artery disease	3.46e-06	3.74e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CREB1—coronary artery disease	3.46e-06	3.74e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HIF1A—coronary artery disease	3.44e-06	3.71e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—LPL—coronary artery disease	3.44e-06	3.71e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AGT—coronary artery disease	3.43e-06	3.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL2—coronary artery disease	3.39e-06	3.66e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6R—coronary artery disease	3.38e-06	3.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA2—coronary artery disease	3.38e-06	3.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.38e-06	3.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX2—coronary artery disease	3.38e-06	3.65e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—coronary artery disease	3.36e-06	3.63e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—coronary artery disease	3.36e-06	3.63e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—coronary artery disease	3.36e-06	3.63e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF2—coronary artery disease	3.35e-06	3.62e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—coronary artery disease	3.35e-06	3.62e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.34e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.34e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HK1—coronary artery disease	3.34e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX4—coronary artery disease	3.34e-06	3.6e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—coronary artery disease	3.33e-06	3.6e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOA1—coronary artery disease	3.32e-06	3.58e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK1—coronary artery disease	3.31e-06	3.58e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—coronary artery disease	3.31e-06	3.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HADHA—coronary artery disease	3.3e-06	3.56e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KDR—coronary artery disease	3.29e-06	3.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK14—coronary artery disease	3.27e-06	3.53e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CD36—coronary artery disease	3.27e-06	3.53e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.26e-06	3.52e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.23e-06	3.48e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPP2CA—coronary artery disease	3.22e-06	3.48e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPA—coronary artery disease	3.22e-06	3.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JAK2—coronary artery disease	3.22e-06	3.47e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.2e-06	3.45e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.18e-06	3.44e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—coronary artery disease	3.17e-06	3.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—F2—coronary artery disease	3.17e-06	3.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FN1—coronary artery disease	3.17e-06	3.42e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—coronary artery disease	3.16e-06	3.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6ST—coronary artery disease	3.15e-06	3.41e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—coronary artery disease	3.15e-06	3.4e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAT—coronary artery disease	3.14e-06	3.39e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NFKBIA—coronary artery disease	3.13e-06	3.38e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.12e-06	3.37e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—coronary artery disease	3.09e-06	3.34e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA5—coronary artery disease	3.09e-06	3.34e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—coronary artery disease	3.07e-06	3.32e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF2—coronary artery disease	3.06e-06	3.31e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOB—coronary artery disease	3.05e-06	3.29e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KIT—coronary artery disease	3.03e-06	3.27e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—P4HB—coronary artery disease	3.03e-06	3.27e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—coronary artery disease	3.02e-06	3.26e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—coronary artery disease	2.99e-06	3.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.97e-06	3.21e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—coronary artery disease	2.96e-06	3.2e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AGT—coronary artery disease	2.94e-06	3.18e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JAK2—coronary artery disease	2.93e-06	3.17e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—coronary artery disease	2.93e-06	3.17e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—LPL—coronary artery disease	2.91e-06	3.14e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GSK3B—coronary artery disease	2.91e-06	3.14e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—coronary artery disease	2.88e-06	3.12e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CREB1—coronary artery disease	2.88e-06	3.12e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—coronary artery disease	2.88e-06	3.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—coronary artery disease	2.88e-06	3.11e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOA1—coronary artery disease	2.85e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—coronary artery disease	2.84e-06	3.07e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—coronary artery disease	2.83e-06	3.06e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL2—coronary artery disease	2.82e-06	3.05e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6R—coronary artery disease	2.81e-06	3.04e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—coronary artery disease	2.81e-06	3.03e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—VCAN—coronary artery disease	2.8e-06	3.03e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—coronary artery disease	2.79e-06	3.01e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.78e-06	3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—coronary artery disease	2.77e-06	3e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CD36—coronary artery disease	2.76e-06	2.99e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—coronary artery disease	2.73e-06	2.95e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.73e-06	2.95e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DCN—coronary artery disease	2.7e-06	2.92e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—coronary artery disease	2.68e-06	2.89e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—coronary artery disease	2.65e-06	2.87e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	2.63e-06	2.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.63e-06	2.84e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.62e-06	2.83e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	2.59e-06	2.79e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—coronary artery disease	2.57e-06	2.78e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—coronary artery disease	2.56e-06	2.77e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HBA1—coronary artery disease	2.56e-06	2.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LIPC—coronary artery disease	2.56e-06	2.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.56e-06	2.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.56e-06	2.76e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF2—coronary artery disease	2.55e-06	2.75e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—coronary artery disease	2.55e-06	2.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOC3—coronary artery disease	2.54e-06	2.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LDLR—coronary artery disease	2.53e-06	2.73e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—coronary artery disease	2.52e-06	2.72e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—coronary artery disease	2.51e-06	2.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.5e-06	2.7e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.5e-06	2.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—coronary artery disease	2.5e-06	2.7e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AGT—coronary artery disease	2.49e-06	2.69e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—coronary artery disease	2.47e-06	2.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCLC—coronary artery disease	2.47e-06	2.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CETP—coronary artery disease	2.47e-06	2.67e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JAK2—coronary artery disease	2.44e-06	2.64e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SDC1—coronary artery disease	2.44e-06	2.64e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—coronary artery disease	2.44e-06	2.63e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—coronary artery disease	2.42e-06	2.62e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOA1—coronary artery disease	2.41e-06	2.6e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—coronary artery disease	2.38e-06	2.57e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	2.35e-06	2.54e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.31e-06	2.49e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.31e-06	2.49e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.31e-06	2.49e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—coronary artery disease	2.26e-06	2.44e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CTGF—coronary artery disease	2.25e-06	2.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.23e-06	2.41e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT2—coronary artery disease	2.23e-06	2.41e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—coronary artery disease	2.23e-06	2.41e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—coronary artery disease	2.19e-06	2.36e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	2.18e-06	2.35e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—coronary artery disease	2.16e-06	2.33e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK1—coronary artery disease	2.15e-06	2.32e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—coronary artery disease	2.14e-06	2.31e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—coronary artery disease	2.12e-06	2.29e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—coronary artery disease	2.09e-06	2.26e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—coronary artery disease	2.08e-06	2.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.05e-06	2.22e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—coronary artery disease	2.02e-06	2.18e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	2e-06	2.16e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.99e-06	2.15e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.97e-06	2.13e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.96e-06	2.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GGT1—coronary artery disease	1.93e-06	2.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT1—coronary artery disease	1.93e-06	2.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—coronary artery disease	1.91e-06	2.06e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—coronary artery disease	1.89e-06	2.04e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	1.86e-06	2.01e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—coronary artery disease	1.83e-06	1.97e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—coronary artery disease	1.81e-06	1.96e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—coronary artery disease	1.78e-06	1.92e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.73e-06	1.87e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.72e-06	1.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.71e-06	1.84e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	1.7e-06	1.84e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAT—coronary artery disease	1.68e-06	1.82e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.67e-06	1.8e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—coronary artery disease	1.66e-06	1.8e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—coronary artery disease	1.65e-06	1.78e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOB—coronary artery disease	1.64e-06	1.77e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK1—coronary artery disease	1.63e-06	1.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.59e-06	1.72e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPL—coronary artery disease	1.56e-06	1.69e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—coronary artery disease	1.54e-06	1.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—coronary artery disease	1.52e-06	1.65e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—coronary artery disease	1.52e-06	1.64e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—coronary artery disease	1.5e-06	1.63e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CD36—coronary artery disease	1.48e-06	1.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.47e-06	1.58e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	1.42e-06	1.53e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.41e-06	1.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—coronary artery disease	1.39e-06	1.5e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AGT—coronary artery disease	1.34e-06	1.44e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—coronary artery disease	1.31e-06	1.41e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA1—coronary artery disease	1.29e-06	1.4e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—coronary artery disease	1.25e-06	1.35e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.21e-06	1.31e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—coronary artery disease	1.16e-06	1.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—coronary artery disease	1.14e-06	1.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—coronary artery disease	1.12e-06	1.21e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—coronary artery disease	1.03e-06	1.11e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—coronary artery disease	9.92e-07	1.07e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—coronary artery disease	9.81e-07	1.06e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.97e-07	9.69e-06	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—coronary artery disease	8.4e-07	9.07e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.52e-07	5.96e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—coronary artery disease	4.51e-07	4.87e-06	CbGpPWpGaD
